Close
Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
GBCC
Previous Meetings
GBCC Information
GBCC Resources
Previous Meetings
Photo Album
Announcement
What’s NEW
Previous Meetings (GBCC 2023)
※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.
Day 1, Apr 27 (Thu) Day 2, Apr 28 (Fri) Day 3, Apr 29 (Sat)
09:00-10:15
  • Panel Discussion 1: 
    How to Manage Old-aged Breast Cancer Patients?  
    Venue: RM 2(Vista 3)
  • Education Session 1: 
    Radiologist’s Perspectives on Neoadjuvant Systemic Therapy in Breast Cancer  
    Venue: RM 3(Walker Hall 1)
  • Causes of Over- and Underestimation of Tumor and Axillary LN After Neoadjuvant System Therapy
    Beatriu Reig 
    (NYU Langone Health, U.S.A.)
    Slide ViewVideo ViewAbstract
  • Evaluation of Response to Neoadjuvant Systemic Therapy: Multiparametric Approach for Accurate Evaluation of Residual Tumor
    Masako Kataoka 
    (Kyoto Univ., Japan)
    Slide ViewVideo ViewAbstract
  • How to Manage Residual Microcalcifications After Neoadjuvant Chemotherapy
    Sung Hun Kim 
    (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
    Slide ViewVideo ViewAbstract
  • Symposium 1: 
    Recent Strategies for ER+/HER2- Breast Cancer  
    Venue: RM 1(Vista 1+2)
  • Optimal Duration of Endocrine Therapy
    Polly Suk Yee Cheung 
    (Hong Kong Sanatorium and Hospital, Hong Kong)
    Slide ViewVideo ViewAbstract
  • The Role of CDK4/6 Inhibitors in ER+/HER2- Early Breast Cancer
    Tadahiko Shien 
    (Okayama Univ. Hospital, Japan)
    Slide ViewVideo ViewAbstract
  • ER+/HER2 Negative Premenopausal Breast Cancer- The Biomarker Way Forward
    Peter C. Dubsky 
    (Hirslanden Klinik St. Anna, Switzerland)
    Slide ViewVideo ViewAbstract
  • Oral Presentation 1
      
    Venue: RM 4(Walker Hall 2)
  • GBCC-SSO Joint Session: 
    Management of Hereditary Breast Cancer - Global Perspectives of Surgical Oncologists  
    Venue: RM 5(Art Hall)
  • Management of Hereditary Breast Cancer in the U.S.
    Tolga Ozmen 
    (Massachusetts General Hospital, U.S.A.)
    Abstract
  • Management of Hereditary Breast Cancer in Europe
    Isabel T. Rubio 
    (Clinica Universidad de Navarra, Spain)
    Slide ViewVideo ViewAbstract
  • Management of Hereditary Breast Cancer in Asia
    Sung-Won Kim 
    (Daerim St. Mary's Hospital, Korea)
    Slide ViewVideo ViewAbstract
10:30-11:45
  • Education Session 2: 
    Genomic Assays and Treatment Decision  
    Venue: RM 3(Walker Hall 1)
  • Optimal Decisions on Adjuvant Endocrine and Chemotherapy Using Multigene Assays
    Chi-Cheng Huang 
    (Taipei Veterans General Hospital, Taiwan)
    Slide ViewVideo ViewAbstract
  • Clinical Parameters as Alternatives to Genomic Assays
    Jong Won Lee 
    (ASAN Medical Center, Korea)
    Slide ViewVideo ViewAbstract
  • Interpretation of Genomic Assays in Premenopausal Women
    Kevin Kalinsky 
    (Winship Cancer Institute of Emory Univ., U.S.A.)
    Slide ViewVideo ViewAbstract
  • Panel Discussion 2: 
    Various Considerations in Premenopausal Breast Cancer Patients  
    Venue: RM 2(Vista 3)
  • The Optimal Endocrine Combination with OFS
    Hee Jeong Kim 
    (ASAN Medical Center, Korea)
    Slide ViewVideo ViewAbstract
  • Targeted Therapy for High-risk Patients and gBRCA Mutation Patients
    Hee Kyung Ahn 
    (Gachon Univ. Gil Medical Center, Korea)
    Slide ViewVideo View
  • Prophylactic Mastectomy
    Eric Schneider 
    (Yale School of Medicine, U.S.A.)
  • Symposium 2: 
    HER2-Low as a Targetable Subset of Breast Cancer  
    Venue: RM 1(Vista 1+2)
  • Is HER2-Low Breast Cancer an Independent/Distinctive Subtype?
    Naoto Ueno 
    (Univ. of Hawai'i Cancer Center, U.S.A.)
    Slide ViewVideo ViewAbstract
  • How to Identify HER2-Low Breast Cancer
    Hee Jin Lee 
    (ASAN Medical Center, Korea)
    Abstract
  • Targeting HER2-Low and the Treatment Sequence
    Wei-Pang Chung 
    (National Cheng Kung Univ. Hospital, Taiwan)
    Slide ViewVideo ViewAbstract
  • Oral Presentation 2
      
    Venue: RM 4(Walker Hall 2)
  • GBCC-JBCS Joint Session: 
    Holistic Management for Breast Cancer Patients in Pandemic Era  
    Venue: RM 5(Art Hall)
12:00-12:45
  • Plenary Lecture 1
      
    Venue: RM 1(Vista 1+2)
  • A Revolution in the Making: How Antibody-Drug Conjugates are Transforming Breast Cancer Treatment
    Ian Krop 
    (Yale School of Medicine, U.S.A.)
    Slide ViewVideo ViewAbstract
13:00-13:45
  • Satellite Symposium 1: 
    MSD Korea  
    Venue: RM 1(Vista 1+2)
14:00-14:45
  • Plenary Lecture 2
      
    Venue: RM 1(Vista 1+2)
15:00-16:15
  • Panel Discussion 3: 
    Optimal Surgical Treatment After Neoadjuvant Chemotherapy  
    Venue: RM 2(Vista 3)
  • Avoiding Breast Surgery in Patients with Radiologic Complete Response
    Christoph Tausch 
    (Breast-Center Zurich, Switzerland)
    Slide ViewVideo ViewAbstract
  • De-escalation of Sentinel Lymph Node Biopsy in Patients with Radiologic Complete Response
    Shih-Che Shen 
    (Chang Gung Memorial Hospital, Taiwan)
    Abstract
  • De-escalation of Radiotherapy in Patients Achieved Pathologically Complete Response
    Yeon-Joo Kim 
    (National Cancer Center, Korea)
    Slide ViewVideo ViewAbstract
  • Oral Presentation 3
      
    Venue: RM 4(Walker Hall 2)
  • Symposium 3: 
    Beyond CDK4/6 Inhibitor: New Target and New Drugs  
    Venue: RM 3(Walker Hall 1)
  • Novel Oral SERD and its Implication in Clinical Practice
    Yen-Shen Lu 
    (National Taiwan Univ. Hospital, Taiwan)
    Slide ViewVideo ViewAbstract
  • Treatment Strategy After Progression on CDK4/6 Inhibitor
    Nadia Harbeck 
    (LMU Univ. Hospital, Germany)
    Abstract
  • New Targets Beyond CDK4/6 Inhibitor: Development in Progress
    Yong Wha Moon 
    (CHA Bundang Medical Center, Korea)
    Abstract
  • GBCC-TBCS Joint Session: 
    Making Evidences Together  
    Venue: RM 5(Art Hall)
16:30-17:45
  • Education Session 3: 
    Special Issues in Young Women with Breast Cancer Treated with Radiotherapy  
    Venue: RM 2(Vista 3)
  • Breast Radiotherapy During Pregnancy
    Stefanie Corradini 
    (Univ. Hospital, LMU Munich, Germany)
    Slide ViewVideo ViewAbstract
  • Risk of Contralateral Breast Cancer After Breast Radiotherapy in Young Women
    Seung Won Seol 
    (Univ. of Pennsylvania, U.S.A.)
    Slide ViewVideo ViewAbstract
  • Heart Disease After Breast Radiotherapy in Young Women
    Ji Hyeon Joo 
    (Pusan National Univ. Yangsan Hospital, Korea)
    Slide ViewVideo ViewAbstract
  • Symposium 4: 
    Tailored Surgery in Early-stage Breast Cancer  
    Venue: RM 3(Walker Hall 1)
  • Individualized Surgical Extent and Lumpectomy Margin in Early-stage Breast Cancer: Does Tumor Histology and Subtype Matter?
    Naoki Hayashi 
    (Showa Univ. School of Medicine, Japan)
    Abstract
  • The Role of Axillary Surgery for DCIS and Early-stage Breast Cancer
    Wonshik Han 
    (Seoul National Univ. Hospital, Korea)
    Slide ViewVideo ViewAbstract
  • Pre-operative Genomic Assay for Breast Surgery Guidance in HR+/HER2- Breast Cancer
    Caroline Drukker 
    (Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Netherlands)
    Slide ViewVideo ViewAbstract
  • Oral Presentation 4
      
    Venue: RM 4(Walker Hall 2)
  • GBCC-CACA Joint Session: 
    Programs for Breast Cancer Screening and Prevention  
    Venue: RM 5(Art Hall)
  • KBCS Guidelines of Screening and Current Status
    Young-Joon Kang 
    (The Catholic Univ. of Korea, Incheon St. Mary's Hospital, Korea)
    Slide ViewVideo ViewAbstract
  • CACA Guidelines of Screening and Current Status
    Yongsheng Wang 
    (Shandong Cancer Hospital & Institute, China)
    Slide ViewVideo View
  • Korean Recommendations for Prevention and Risk Managements
    Yoo Seok Kim 
    (Chosun Univ. Hospital, Korea)
    Slide ViewVideo View
  • Chinese Recommendations for Prevention and Risk Managements
    Junjie Li 
    (Fudan Univ. Shanghai Cancer Center, China)


Back to Previous Meetings+



Global Breast Cancer Conference Secretariat

Partner I INTERCOM Convention Services, Inc. (Core PCO)

TOP